These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21075429)

  • 1. Interindividual variability of in vitro response to anticoagulants.
    Samama MM
    Thromb Res; 2011 Jan; 127(1):1. PubMed ID: 21075429
    [No Abstract]   [Full Text] [Related]  

  • 2. Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography.
    Hacquard M; Perrin J; Lelievre N; Vigneron C; Lecompte T
    Thromb Res; 2011 Jan; 127(1):29-34. PubMed ID: 20850172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis.
    Potze W; Arshad F; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Lisman T
    Br J Haematol; 2013 Dec; 163(5):666-73. PubMed ID: 24219333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a rebuttal.
    Hemker HC; Béguin S
    J Thromb Haemost; 2013 Mar; 11(3):564. PubMed ID: 23289967
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-molecular-weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a reply to rebuttal.
    Buyue Y; Misenheimer TM; Sheehan JP
    J Thromb Haemost; 2013 Mar; 11(3):565-6. PubMed ID: 23332108
    [No Abstract]   [Full Text] [Related]  

  • 6. Mode of action of heparin and related drugs.
    Hemker HC; Beguin S
    Semin Thromb Hemost; 1991; 17 Suppl 1():29-34. PubMed ID: 1648791
    [No Abstract]   [Full Text] [Related]  

  • 7. Three different patterns of calibrated automated thrombogram obtained with six different anticoagulants.
    Samama MM; Le Flem L; Guinet C; Gerotziafas G; Depasse F
    J Thromb Haemost; 2007 Dec; 5(12):2554-6. PubMed ID: 18034769
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
    Gatt A; van Veen JJ; Woolley AM; Kitchen S; Cooper P; Makris M
    Thromb Haemost; 2008 Aug; 100(2):350-5. PubMed ID: 18690358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH.
    Dargaud Y; Wolberg AS; Gray E; Negrier C; Hemker HC;
    J Thromb Haemost; 2017 Aug; 15(8):1704-1707. PubMed ID: 28656617
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequence determination and anticoagulant and antithrombotic activities of a novel sulfated fucan isolated from the sea cucumber Isostichopus badionotus.
    Chen S; Hu Y; Ye X; Li G; Yu G; Xue C; Chai W
    Biochim Biophys Acta; 2012 Jul; 1820(7):989-1000. PubMed ID: 22446377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency.
    Sinauridze EI; Vuimo TA; Tarandovskiy ID; Ovsepyan RA; Surov SS; Korotina NG; Serebriyskiy II; Lutsenko MM; Sokolov AL; Ataullakhanov FI
    Talanta; 2018 Apr; 180():282-291. PubMed ID: 29332812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban.
    Harenberg J; Marx S; Weiss C; Krämer R; Samama M; Schulman S;
    J Thromb Haemost; 2012 Jul; 10(7):1433-6. PubMed ID: 22947062
    [No Abstract]   [Full Text] [Related]  

  • 15. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma.
    Baier K; Cvirn G; Fritsch P; Köstenberger M; Gallistl S; Leschnik B; Muntean W
    Pediatr Res; 2005 May; 57(5 Pt 1):685-9. PubMed ID: 15718352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facts and artefacts of coagulation assays for factor Xa inhibitors.
    Haas S
    Thromb Haemost; 2010 Apr; 103(4):686-8. PubMed ID: 20174751
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competition of unfractionated heparin and idraparinux on activated partial thromboplastin time and effect of exogenous antithrombin.
    Gouin-Thibault I; Samama MM
    Thromb Haemost; 2009 May; 101(5):986-7. PubMed ID: 19404557
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
    Samama MM; Martinoli JL; LeFlem L; Guinet C; Plu-Bureau G; Depasse F; Perzborn E
    Thromb Haemost; 2010 Apr; 103(4):815-25. PubMed ID: 20135059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation monitoring.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):283-304. PubMed ID: 19665679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.